Stock Price Quote

CEPHAM PHARMACEUTICALS LTD.

NSE : NABSE : 524123ISIN CODE : Industry : Consumer FoodHouse : Private
BSE0.000 (0 %)
PREV CLOSE ( ) NA
OPEN PRICE ( ) 0.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 0
TODAY'S LOW / HIGH ( )0.00 0.00
52 WK LOW / HIGH ( ) 00
NSE
This Company is not listed in NSE
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year :
Management Info
- Chairman - Managing Director
Registered Office

Address Not Available

Phone Not Available

Email Not Available

Website Not Available

Registrars Details
Not Available
Listing :

NEWS

No News Found

Financials

in Millions
QTR ANNUAL
Net Profit
Gross Profit
Operating Profit
Net Sales

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

KSE (BSE)
peergroup  2013.70 (5.00%)
M.Cap ( in Cr)644.38
Vadilal Enterprise (BSE)
peergroup  3780.00 (2.13%)
M.Cap ( in Cr)326.09
Nestle (BSE)
peergroup  2502.20 (2.33%)
M.Cap ( in Cr)241251.40
Vadilal Industries (BSE)
peergroup  4943.95 (0.80%)
M.Cap ( in Cr)3553.63
Zydus Wellness (BSE)
peergroup  1776.75 (2.15%)
M.Cap ( in Cr)11305.84

Shareholding Pattern

No Data Found

About

no data found

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.